FORD OTOMOTİV SANAYİ A.Ş.

Pre-Annual General Meeting Information • Feb 28, 2025

AGENDA OF FORD OTOMOTİV SANAYİ A.Ş. ORDINARY GENERAL ASSEMBLY MEETING DATED MARCH 26, 2025

• 1. Openng and electon of Charmanshp Panel,
• 2. Reading, discussion and approval of the Annual Report of year 2024 prepared by the Board of Directors,
• 3. Reading of the summary report of the Independent Audit Firm of 2024 Fiscal Period,
• 4. Reading, discussion and approval of the Financial Statements of 2024 Fiscal Period,
• 5. Release of the members of the Board of Directors separately for year 2024 activities,
• 6. Approval, or approval with amendments or refusal of the Board of Directors' proposal for profit distribution for the year 2024 and the distribution date which prepared in accordance with the Company's Profit Distribution Policy,
• 7. Determination of the number and the term of duty of the members of the Board of Directors and election of the members base on the determined number, election of the Independent Board Members,
• 8. As per the Corporate Governance Principles, informing the shareholders regarding the "Remuneration Policy" for members of the Board of Directors and the senior executives and payments made under this policy and approval of the "Remuneration Policy" and related payments,
• 9. Determination of the annual gross fees to be paid to the members of the Board of Directors,
• 10. As per the regulations of the Turkish Commercial Code and Capital Markets Board, approval of the Board of Directors' election for the Independent Audit Firm,
• 11. Giving information to the shareholders regarding the donations made by the Company in 2024 and determination of a upper limit for donations to be made in 2025,
• 12. In accordance with the Capital Markets Board regulations, presentation to the shareholders of the securities, pledges and mortgages granted in favor of the third parties in the year 2024 and of any benefits or income thereof,
• 13. Under Articles 395 and 396 of the Turkish Commercial Code, authorizing: shareholders with management control, members of the Board of Directors, senior executives and their spouses and relatives related by blood or affinity up to the second degree; and also informing the shareholders regarding the transactions made in this extent in 2024 pursuant to the Capital Markets Board's Communiqué on Corporate Governance,
• 14. Informing the shareholders about the Company's target and progress towards transitioning to a low-carbon economy and the activities carried out in 2024 within this scope,
• 15. Wishes and opinions